.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Farmers Insurance
Daiichi Sankyo
Cipla
Cantor Fitzgerald
Moodys
Chubb
Fish and Richardson
Accenture
Covington

Generated: June 25, 2017

DrugPatentWatch Database Preview

Cariprazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for cariprazine hydrochloride and what is the scope of cariprazine hydrochloride freedom to operate?

Cariprazine hydrochloride
is the generic ingredient in one branded drug marketed by Forest Res Inst Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cariprazine hydrochloride has sixty-two patent family members in thirty-five countries.

There is one drug master file entry for cariprazine hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: cariprazine hydrochloride

Tradenames:1
Patents:3
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list9
Clinical Trials: see list2,263
Patent Applications: see list31
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cariprazine hydrochloride at DailyMed

Pharmacology for Ingredient: cariprazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-004Sep 17, 2015RXYesYes7,737,142► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-003Sep 17, 2015RXYesNo► Subscribe► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-003Sep 17, 2015RXYesNo7,943,621► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-004Sep 17, 2015RXYesYes► Subscribe► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-001Sep 17, 2015RXYesNo7,737,142► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: cariprazine hydrochloride

Country Document Number Estimated Expiration
Eurasian Patent Organization017270► Subscribe
Malaysia148078► Subscribe
Israel172746► Subscribe
Taiwan200505874► Subscribe
Iceland8199► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Baxter
Chinese Patent Office
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Fish and Richardson
Covington
Cipla
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot